Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02066103 : Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Life expectancy of at least 12 weeks

- Adequate bone marrow, liver, and renal function

- Scheduled to undergo bronchoscopy for malignant airway obstruction as standard
medical care

- Pathologically confirmed, unresectable primary or recurrent non-small cell lung

- Measurable disease with obstruction into the airway

- Pathologically confirmed, unresectable primary or recurrent non-small cell lung

- Patients undergo recanalization procedure of tumor during bronchoscopy

- Investigator is able to insert and deploy the Blowfish Catheter into the airway after

Exclusion Criteria:

- Second primary malignancy, except for non-melanoma skin cancer and in situ cervical

- Pregnant or nursing female subjects, or female subjects of child bearing potential
who refuse to take a pregnancy test prior to their enrollment in this study

- Uncontrolled infection

- Presence or recent history of any systemic disorder or conditions, such as:

- uncontrolled hypertension

- type 1 diabetes

- severe pulmonary hypertension

- acute kidney injury

- stroke (within the last 6 month)

- myocardial infarction (within the last 3 months)

- Individuals with neurological, mental or psychiatric disorders

- Concurrent participation in another study involving investigational drugs or
investigational medical devices

- Other (non-cancer) disease not stabilized within 1 month before the Screening Visit

- Known hypersensitivity to paclitaxel, Cremophor EL, or iodinated contrast media

- Any serious, uncontrolled comorbidity or condition that an Investigator believes
would interfere with the intent of the study or would make participation not in the
best interest of the patient Intraoperative Exclusion Criteria

- Use of pulmonary airway stents and/or ongoing or initiation of local external beam or
brachytherapy radiation

- Any intraoperative complications that per the investigator's judgment increase the
risk to the patient.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557